🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04010214
Recruiting Observational

A Registered Cohort Study on Cerebellar Ataxia in the Organization in South-East China for Cerebellar Ataxia Research (OSCCAR)

NCT04010214 · tracked via the Priya Life Science China tracker
Sponsor
Ning Wang, MD., PhD.
Phase
Observational
Started
2019-07-01
Last updated
2023-07-12

Condition(s) studied

Cerebellar Ataxia

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

Cerebellar ataxia is a form of ataxia originating in the cerebellum. Cerebellar ataxia can occur as a result of many diseases and may present with symptoms of an inability to coordinate balance, gait, extremity and eye movements. To understand the clinical and genetic characteristics of cerebellar ataxia, we establish a registered cohort to follow up Chinese patients with cerebellar ataxia.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Patients with cerebellar ataxia based on the diagnoses of tow neurologists * Relatives of patients with cerebellar ataxia * Unrelated healthy controls * Participants or legal guardian(s) willing and able to complete the informed consent process Exclusion Criteria: * Participants are unable to comply with trial procedures and visit schedule

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Neurology ,First Affiliated Hospital Fujian Medical University Fuzhou Fujian Recruiting

More Ning Wang, MD., PhD. trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04010214 on ClinicalTrials.gov ↗ ← All trials in China